This report analyzes the disruptive themes that have driven M&A activity in Q2 2025 in the Medical Devices Sector
The global medical devices market witnessed deals worth $8 billion in Q2 2025, a decrease of 80% compared to Q2 2024. The sector recorded deal value worth $2 billion mega-deals (defined as any deal valued at more than $1 billion), a decrease of 72% compared to Q2 2024.Scope
- This report provides an overview of merger and acquisition activity globally in Q2 2025 in Medical Devices Sector
- It identifies the themes driving most notable to deals announced in Q2 2025 in the Medical Devices Sector
Reasons to Buy
- Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
- In this report we have listed down the most notable deals in medical devices sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Table of Contents
- Executive Summary
- Review of the Medical Devices M&A Market - Q2 2025
- Medical Devices M&A Deals Analysis by Geography - Q2 2025
- Further Reading
- Appendix 1: Deal Selection Criteria
- Appendix 2: Thematic Research Methodology
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BioNTech SE
- RWK BidCo AB
- Demant A/S
- Tokuyama Corp
- TecMed AG
- Illumina Inc
- TTAM Research Institute
- BioMarin Pharmaceutical Inc
- Tibet Trust Co Ltd
- Braidwell
- First Light Asset Management, LLC
- Ghisallo Capital Management LLC
- Millennium Management LLC
- Perceptive Advisors LLC
- Woodline Partners
- Aldrich Capital Partners
- RadNet Inc
- Quidelortho Corp
- TIS International (USA) Inc
- Hipro Biotechnology Co Ltd
- Seatown Holdings International Pte. Ltd.
- Zongteng Group
- Sartorius Lab Holding GmbH
- Google LLC
- Qiagen NV
- Curevac NV
- Biotage AB
- Kind Consumer Ltd
- JSR Corp
- Ypsomed
- SomaLogic Inc
- 23andMe Holding Co
- Inozyme Pharma Inc
- Xiamen Amoytop Biotech Co Ltd
- Caris Life Sciences Inc
- Persivia Inc
- iCAD Inc
- LEX Diagnostics Ltd
- TIS International
- Qlife Holding AB
- AddVita Pte Ltd
- Lifecome Biochemistry Co Ltd
- MatTek Corp
- Visikol Inc
- Warby Parker Inc
- Genoox Ltd
